Search clinical trials for: Fluocinolone acetonide .1%, hydroquinone 4%, tretinoin .05%
Total 29 results
-
Galderma R&DCompleted
-
Jinnah Postgraduate Medical CentreActive, not recruiting
-
Galderma R&DTerminated
-
Galderma R&DCompleted
-
Duke UniversityCompletedPosterior Uveitis | Intermediate UveitisUnited States
-
Imperial College LondonWithdrawnDiabetes | Diabetic Macular Edema
-
Arno TherapeuticsCompletedLymphoma | Solid TumorsUnited States, United Kingdom
-
AstraZenecaCompletedRheumatoid ArthritisUnited Kingdom
-
AstraZenecaCompletedRheumatoid ArthritisUnited Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARAUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Virginia Clinical Research, Inc.Celgene CorporationUnknownLichen PlanusUnited States
-
AstraZenecaCompletedHealthy Volunteers | PharmacokineticsGermany
-
AstraZenecaCompletedHealthy Volunteers | PharmacokineticsUnited Kingdom
-
AstraZenecaQuintiles, Inc.CompletedRheumatoid ArthritisUnited Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyeloid Neoplasm | Childhood Acute Promyelocytic Leukemia With PML-RARAUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)Not yet recruitingMetastatic Osteosarcoma | Localized Osteosarcoma | Unresectable Osteosarcoma | Resectable Osteosarcoma
-
British Columbia Cancer AgencyHoffmann-La RocheCompleted
-
Hitit UniversityCompletedAdhesive CapsulitisTurkey
-
AstraZenecaCompletedRheumatoid ArthritisBulgaria, Czech Republic, Poland, Russian Federation, Hungary, Romania, Ukraine, Slovakia, South Africa, Serbia, Colombia, Italy, Latvia, Malta
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | GliosarcomaUnited States
-
National Cancer Institute (NCI)CompletedMedulloblastoma | Pineoblastoma | Supratentorial Embryonal Tumor, Not Otherwise SpecifiedUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia
-
National Cancer Institute (NCI)RecruitingNeuroblastoma | GanglioneuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | GanglioneuroblastomaUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States